Skip to main content
. 2023 Nov 9;7(4):72. doi: 10.3390/vision7040072

Table 2.

Differential diagnosis amongst NA-AION, A-AION, optic neuritis, anterior orbital lesions.

Clinical Features NA-AION A-AION Papillitis Orbital Lesions
Patient’s age any, most frequent over 50 years over 50 years, most frequent over 70 years any, most common in young any
Gender predilection male female female any
Visual loss onset acute acute, poor VA * semi-acute gradually slowly progressive
Onset laterality unilateral unilateral or bilateral (30% of cases) unilateral unilateral
Visual field defect pattern altitudinal or arcuate altitudinal or arcuate central, centro-cecal, arcuate arcuate, peripheral
OD edema any type, segmental, evolution to OD atrophy chalky white, segmental, evolution to OD cupping mild, hyperemic, evolution to OD atrophy pale, lasting over 4–6 weeks, evolution to OD atrophy
OD the fellow eye at onset small C/D normal or large C/D normal or large C/D normal or large C/D
Peripapillary hemorrhages common common uncommon uncommon
Relative afferent pupillary defect present present present present
Ocular pain uncommon (10–15% of cases) common (75% of cases) common (95% of cases), worse with eye movements common
Premonitory symptoms uncommon amaurosis fugax and/or diplopia (30% of cases) uncommon uncommon
Associated ocular finding OD drusen, hypertensive or diabetic retinopathy cotton wool spots, central retinal o cilioretinal artery occlusion possible intraocular inflammation, retinal vasculitis ptosis, proptosis, lid and eye movements abnormalities
Presence of vasculopatic risk factors common common uncommon uncommon
Associated systemic symptoms absent fever, malaise, jaw claudication, headache, abnormal temporal artery ** paresthesia, diplopia, ataxia, weakness, systemic disease signs of systemic malignancy may be present
Disease course frequent spontaneous visual recovery rare spontaneous visual recovery, severe prognosis frequent spontaneous visual recovery progressively worse
FAG features of OD ischemia common common and severe absent absent
serous ESE and CRP levels normal significantly high normal normal
MRI brain and orbit findings none ON sheath and orbital fat enhancement ON enhancement; frequent signs of demyelination presence of orbital compressive lesions
Response to CS therapy unclear present, stop of further vision loss and systemic complications present, with good visual prognosis absent

NA-AION = non-arteritic anterior ischemic optic neuropathy; A-AION = arteritic anterior ischemic optic neuropathy; OD = optic disk; C/D = cup-to-disk ratio; ON = optic nerve; CS = corticosteroids; CRP = C-reactive protein; * = VA at onset ≤ counter finger in >50% of cases; ** = 25% of A-AION are “occult”, i.e., without systemic symptoms.